Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IDB VisionCare is a Malaysian pharmaceutical and medical device company specializing in ophthalmology, with a primary focus on pediatric eye care and myopia management. The company is best known for its flagship product, Myopine, a low-dose atropine eye drop formulation developed in collaboration with the Singapore National Eye Centre (SNEC) to slow the progression of myopia in children. In addition to pharmaceutical treatments, IDB VisionCare provides medical devices such as the Eye Drop Aid, which assists patients in the precise and hygienic administration of ocular medications. The company is actively expanding its presence in the Southeast Asian region through clinical development partnerships and product distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IDB VisionCare.